Coronary Pressure Market Report 2025

This Coronary Pressure market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The coronary pressure market size has grown rapidly in recent years. It will grow from $17.38 billion in 2024 to $19.15 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to the rising incidence of cardiovascular diseases, increasing demand for coronary pressure monitoring, increasing awareness of heart health, and rising healthcare expenditure.

The coronary pressure market size is expected to see strong growth in the next few years. It will grow to $27.95 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to the rising prevalence of coronary artery disease (CAD), the growing geriatric population, the increasing adoption of minimally invasive procedures, and increasing awareness about early disease detection. Major trends in the forecast period include technological advancements, increased cost-effective treatment, improved healthcare access, and launches of new products and services.

The rising prevalence of cardiovascular diseases is expected to drive growth in the coronary pressure market. Cardiovascular diseases encompass a range of conditions affecting the heart and blood vessels, including coronary artery disease, hypertension, and heart failure, which are often associated with lifestyle factors and genetics. The increase in cardiovascular disease rates is attributed to factors such as unhealthy diets, sedentary lifestyles, and rising obesity levels. Coronary pressure devices are essential for assessing and managing these conditions by measuring coronary artery pressures, guiding treatment decisions, and improving patient outcomes. For example, a study published in August 2022 in the Journal of the American College of Cardiology projected an increase in all four cardiovascular risk factors among the U.S. population from 2025 to 2060. The study highlighted diabetes with the highest projected increase at 39.3%, followed by dyslipidemia (27.6%), hypertension (25.1%), and obesity (18.3%). Additionally, significant increases were anticipated in heart failure (33.4%) and ischemic heart disease (30.7%), with heart attack (16.9%) and stroke (33.8%) also showing notable rises. This growing prevalence of cardiovascular diseases is a key driver of the coronary pressure market.

Leading companies in the coronary pressure market are prioritizing the development of innovative products, such as drug-eluting coronary stent systems, to boost treatment effectiveness, lower restenosis rates, and improve long-term patient outcomes. Drug-eluting coronary stent systems are specialized devices that address coronary artery disease by releasing medication directly into the artery through the stent, thereby reducing the risk of restenosis (artery re-narrowing) and promoting better long-term vascular health. For example, in May 2022, Medtronic, an Ireland-based medical device company, obtained FDA approval for its latest generation Onyx Frontier drug-eluting stent. This advanced system is tailored to enhance coronary artery disease treatment by delivering medications that help prevent restenosis after stent placement. The new stent system integrates advanced technology designed to improve patient outcomes and minimize complications associated with coronary procedures.

In May 2024, Johnson & Johnson Services Inc., a US-based pharmaceutical and medical technology company, acquired Shockwave Medical Inc. for an undisclosed amount. This acquisition aims to enhance Johnson & Johnson's presence in the cardiovascular market, improve treatment options for patients, and support long-term financial growth. Shockwave Medical Inc., a US-based provider of coronary pressure devices, will contribute to Johnson & Johnson's expanded portfolio in this sector.

Major companies operating in the coronary pressure market are Cardinal Health Inc., General Electric Company, Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips, Baxter International Inc., Boston Scientific Corporation, Philips Healthcare, Terumo Corporation, Omron Corporation, Edwards Lifesciences, Zoll Medical Corporation, Nihon Kohden Corporation, LivaNova plc, AtriCure, Rossmax, A&D Medical, St. Jude Medical, HeartWare International.

North America was the largest region in the coronary pressure market in 2024. The regions covered in the coronary pressure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coronary pressure market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Coronary pressure is the pressure within the coronary arteries that deliver blood and oxygen to the heart muscle. This measure is vital for evaluating how well blood flow and oxygen are reaching the heart. Factors such as heart rate, blood volume, and arterial resistance affect coronary pressure, making its monitoring key for diagnosing and managing coronary artery disease.

Devices used to measure coronary pressure include sphygmomanometers, automated blood pressure monitors, blood pressure (BP) transducers, and ambulatory blood pressure monitors. A sphygmomanometer is used to manually measure blood pressure and usually features an inflatable cuff, a pressure gauge, and a bulb for inflation. These devices are available in digital, aneroid, and wearable forms and are utilized by various end users such as hospitals, cardiac care centers, ambulatory centers, homecare settings, and academic institutions.

The coronary pressure market research report is one of a series of new reports that provides coronary pressure market statistics, including coronary pressure industry global market size, regional shares, competitors with a coronary pressure market share, detailed coronary pressure market segments, market trends and opportunities, and any further data you may need to thrive in the coronary pressure industry. This coronary pressure market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary pressure market consists of sales of fractional flow reserve (FFR) wire, instantaneous wave-free ratio (iFR) wire, pressure monitoring manifolds, and pressure measurement devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.